These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 39164508)

  • 1. Liver stiffness as a prognostic parameter and tool for risk stratification in advanced cardiac transthyretin amyloidosis.
    Ihne-Schubert SM; Morbach C; Goetze O; Cejka V; Steinhardt MJ; Frantz S; Einsele H; Sommer C; Störk S; Schubert T; Geier A
    Clin Res Cardiol; 2024 Aug; ():. PubMed ID: 39164508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardio-Hepatic Interaction in Cardiac Amyloidosis.
    Ihne-Schubert SM; Goetze O; Gerstendörfer F; Sahiti F; Schade I; Papagianni A; Morbach C; Frantz S; Einsele H; Knop S; Sommer C; Müllhaupt B; Schubert T; Störk S; Geier A
    J Clin Med; 2024 Mar; 13(5):. PubMed ID: 38592299
    [No Abstract]   [Full Text] [Related]  

  • 3. Incremental prognostic utility of congestion markers in cardiac transthyretin amyloidosis.
    Ihne-Schubert SM; Morbach C; Cejka V; Steinhardt MJ; Papagianni A; Frantz S; Einsele H; Wehler T; Kortüm KM; Sommer C; Störk S; Schubert T; Geier A
    Clin Res Cardiol; 2024 Aug; ():. PubMed ID: 39105788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value.
    Cipriani A; De Michieli L; Porcari A; Licchelli L; Sinigiani G; Tini G; Zampieri M; Sessarego E; Argirò A; Fumagalli C; De Gaspari M; Licordari R; Russo D; Di Bella G; Perfetto F; Autore C; Musumeci B; Canepa M; Merlo M; Sinagra G; Gregori D; Iliceto S; Perazzolo Marra M; Cappelli F; Rapezzi C
    JACC CardioOncol; 2022 Nov; 4(4):458-470. PubMed ID: 36444225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, clinical significance and prognosis value of liver stiffness measurement anomalies in transthyretin cardiac amyloidosis.
    Lointier E; Cariou E; Beneyto M; Fournier P; Lavie-Badie Y; Eyharts D; Bureau C; Lairez O;
    Int J Cardiol; 2024 Dec; 416():132485. PubMed ID: 39187068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant Transthyretin Amyloidosis and Severe Aortic Stenosis in Elderly Indian Population: A Pilot Study.
    Singal AK; Bansal R; Singh A; Dorbala S; Sharma G; Gupta K; Saxena A; Bhargava B; Karthikeyan G; Ramakrishnan S; Bisoi AK; Hote MP; Rajashekar P; Chowdhury UK; Devagourou V; Patel C; Ray R; Arawa SK; Mishra S
    JACC CardioOncol; 2021 Oct; 3(4):565-576. PubMed ID: 34746852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial Work Appraisal in Transthyretin Cardiac Amyloidosis and Nonobstructive Hypertrophic Cardiomyopathy.
    de Gregorio C; Trimarchi G; Faro DC; De Gaetano F; Campisi M; Losi V; Zito C; Tamburino C; Di Bella G; Monte IP
    Am J Cardiol; 2023 Dec; 208():173-179. PubMed ID: 37852127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic value of the left atrial myopathy evaluation in cardiac amyloidosis using echocardiography.
    Ferkh A; Geenty P; Stefani L; Emerson P; Pham J; Byth K; Boyd AC; Richards D; Taylor MS; Kwok F; Kizana E; Thomas L
    ESC Heart Fail; 2024 Aug; ():. PubMed ID: 39129371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Experience With the Use of Doxycycline and Ursodeoxycholic Acid for the Treatment of Transthyretin Cardiac Amyloidosis.
    Karlstedt E; Jimenez-Zepeda V; Howlett JG; White JA; Fine NM
    J Card Fail; 2019 Mar; 25(3):147-153. PubMed ID: 30660664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis - Report from the Transthyretin Amyloidosis Outcome Survey (THAOS).
    Kristen AV; Maurer MS; Rapezzi C; Mundayat R; Suhr OB; Damy T;
    PLoS One; 2017; 12(4):e0173086. PubMed ID: 28384285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study.
    Nicol M; Vergaro G; Damy T; Kharoubi M; Baudet M; Canuti ES; Aimo A; Castiglione V; Emdin M; Royer B; Harel S; Cohen-Solal A; Arnulf B; Logeart D
    Front Cardiovasc Med; 2023; 10():1179968. PubMed ID: 37600055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Biomarkers and Their Association with Myocardial Function and Exercise Capacity in Cardiac Transthyretin Amyloidosis.
    Nieto-Roca L; Camblor Blasco A; Devesa A; Gómez-Talavera S; Balaguer-Germán J; Lumpuy-Castillo J; Pello AM; Dhier LM; Lapeña G; Jiménez LL; Lorenzo Ó; Tuñón J; Ibáñez B; Aceña Á
    J Cardiovasc Dev Dis; 2024 Apr; 11(5):. PubMed ID: 38786964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial Work Does Not Have Additional Diagnostic Value in the Assessment of ATTR Cardiac Amyloidosis.
    Henein MY; Lindqvist P
    J Clin Med; 2021 Sep; 10(19):. PubMed ID: 34640569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of cardiopulmonary exercise testing in patients with transthyretin cardiac amyloidosis.
    Silverii MV; Argirò A; Baldasseroni S; Fumagalli C; Zampieri M; Guerrieri L; Bartolini S; Mazzoni C; Burgisser C; Tomberli A; Di Mario C; Marchionni N; Olivotto I; Perfetto F; Fattirolli F; Cappelli F
    Intern Emerg Med; 2023 Mar; 18(2):585-593. PubMed ID: 36396841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of right ventricular myocardial stiffness by cardiac elastography in patients with transthyretin amyloidosis.
    Neto ACA; Pereira NM; Romero CE; Cafezeiro CRF; Bueno BVK; Rissato JH; Pereira FL; Chammas MC; Ramires FJA; Mady C; Junior WM; Filho RK; Fernandes F
    Curr Probl Cardiol; 2024 Oct; 50(1):102867. PubMed ID: 39393619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of tafamidis on myocardial strain in transthyretin amyloid cardiomyopathy.
    Rettl R; Duca F; Binder C; Dachs TM; Cherouny B; Camuz Ligios L; Mann C; Schrutka L; Dalos D; Charwat-Resl S; Badr Eslam R; Kastner J; Bonderman D
    Amyloid; 2023 Mar; 30(1):127-137. PubMed ID: 36251806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
    Castaño A; Narotsky DL; Hamid N; Khalique OK; Morgenstern R; DeLuca A; Rubin J; Chiuzan C; Nazif T; Vahl T; George I; Kodali S; Leon MB; Hahn R; Bokhari S; Maurer MS
    Eur Heart J; 2017 Oct; 38(38):2879-2887. PubMed ID: 29019612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of transthyretin cardiac amyloidosis in patients with heart failure with preserved ejection fraction: the PRACTICA study.
    García-Pavía P; García-Pinilla JM; Lozano-Bahamonde A; Yun S; García-Quintana A; Gavira-Gómez JJ; Aibar-Arregui MÁ; Barge-Caballero G; Núñez Villota J; Bernal L; Tarilonte P
    Rev Esp Cardiol (Engl Ed); 2024 Jul; ():. PubMed ID: 39089574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transthyretin cardiac amyloidosis in patients after TAVR: clinical and echocardiographic findings and long term survival.
    Shimoni S; Zikri M; Haberman D; Livschitz S; Tshori S; Fabricant Y; Meledin V; Gandelman G; Goland S; George J
    ESC Heart Fail; 2021 Dec; 8(6):4549-4561. PubMed ID: 34704399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies.
    Milandri A; Farioli A; Gagliardi C; Longhi S; Salvi F; Curti S; Foffi S; Caponetti AG; Lorenzini M; Ferlini A; Rimessi P; Mattioli S; Violante FS; Rapezzi C
    Eur J Heart Fail; 2020 Mar; 22(3):507-515. PubMed ID: 31975495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.